Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Shorts in action
View:
Post by ScienceFirst on Sep 08, 2022 3:41pm

Shorts in action

Shorts just pumped it (+6% to 0.265$) to then short it (0.24$ -4%) in few trades.

2022-09-08 15:21
0.24
1,000
Anonymous
Virtu ITG Canada Corp.
2022-09-08 15:21
0.23
17,500
TD Securities Inc.
CIBC World Markets Inc.
2022-09-08 15:21
0.24
9,500
Scotia Capital Inc.
CIBC World Markets Inc.
2022-09-08 15:21
0.24
4,000
RBC Capital Markets
CIBC World Markets Inc.
2022-09-08 15:21
0.24
500
Credential Securities Inc.
CIBC World Markets Inc.
2022-09-08 15:21
0.24
4,000
Credential Securities Inc.
CIBC World Markets Inc.
2022-09-08 15:21
0.24
5,000
Credential Securities Inc.
CIBC World Markets Inc.
2022-09-08 15:21
0.24
36,000
TD Securities Inc.
CIBC World Markets Inc.
2022-09-08 15:21
0.24
3,500
TD Securities Inc.
CIBC World Markets Inc.
2022-09-08 15:21
0.25
1,500
Anonymous
CIBC World Markets Inc.
2022-09-08 15:21
0.25
10,000
Scotia Capital Inc.
Anonymous
2022-09-08 15:21
0.25
5,000
Anonymous
Anonymous
2022-09-08 15:21
0.25
4,000
RBC Capital Markets
Scotia Capital Inc.
2022-09-08 15:21
0.25
5,000
Anonymous
Scotia Capital Inc.
2022-09-08 15:21
0.25
2,000
Scotia Capital Inc.
Scotia Capital Inc.
2022-09-08 14:34
0.27
188
TD Securities Inc.
W.D. Latimer Co. Limited
2022-09-08 14:28
0.27
1,000
TD Securities Inc.
CIBC World Markets Inc.
2022-09-08 14:28
0.27
20
W.D. Latimer Co. Limited
Virtu ITG Canada Corp.
2022-09-08 14:27
0.27
300
TD Securities Inc.
W.D. Latimer Co. Limited
2022-09-08 13:46
0.26
9,500
CIBC World Markets Inc.
Scotia Capital Inc.
Comment by Yoly900 on Sep 08, 2022 3:58pm
Something bad must of happened impossible we go down it's over guys tom 0.15 it's all over so much for the goods WE HAVE THE GOODS YES OUR MONEY  
Comment by Yoly900 on Sep 08, 2022 4:09pm
This post has been removed in accordance with Community Policy
Comment by Yoly900 on Sep 08, 2022 4:13pm
This post has been removed in accordance with Community Policy
Comment by Gooseybear on Sep 08, 2022 7:30pm
This post has been removed in accordance with Community Policy
Comment by Yoly900 on Sep 08, 2022 7:40pm
This post has been removed in accordance with Community Policy
Comment by Lesalpes29 on Sep 08, 2022 10:40pm
This post has been removed in accordance with Community Policy
Comment by Yoly900 on Sep 08, 2022 11:08pm
This post has been removed in accordance with Community Policy
Theralase Technologies Inc.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube



INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250